drugset / Trial / NCT02034682

The Effect of Hydroxyethylstarch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte®) Compared to Gelatine (Geloplasma®) on Microvascular Reactivity and Tissue Oxygen Saturation During Haemodilution Measured With Near-infrared Spectroscopy

NCT02034682

Completed 40 enrolled University Hospital, Ghent
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to compare 6% hydroxyethyl starch (HES) 130/0.4 in a balanced electrolyte solution (Volulyte®) with modified fluid gelatin (Geloplasma®) as the priming solution for the cardiopulmonary bypass (CPB) circuit. The microvascular reactivity and the effects on tissue (StO2) and cerebral (ScO2) oxygen saturation will be examined using near-infrared spectroscopy (NIRS).

Timeline

Start
2014-01
Primary completion
2014-08
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject hydroxyethyl starch Other / unclassified 6 % Other
Comparator modified fluid gelatin Other / unclassified Other

Indications

No indication recorded.